Cargando…
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models
BACKGROUND: The majority of high-risk neuroblastomas harbor telomerase activity, and telomerase-interacting compounds, such as 6-thio-2’-deoxyguanosine (6-thio-dG), have been found to impair the growth of telomerase-positive neuroblastoma cell lines. It has remained unclear, however, how such drugs...
Autores principales: | Fischer-Mertens, Janina, Otte, Felix, Roderwieser, Andrea, Rosswog, Carolina, Kahlert, Yvonne, Werr, Lisa, Hellmann, Anna-Maria, Berding, Maya, Chiu, Bill, Bartenhagen, Christoph, Fischer, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579108/ https://www.ncbi.nlm.nih.gov/pubmed/35953764 http://dx.doi.org/10.1007/s13402-022-00702-8 |
Ejemplares similares
-
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
por: Meeser, Alina, et al.
Publicado: (2022) -
Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton
por: MENDER, ILGEN, et al.
Publicado: (2013) -
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017) -
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
por: Rosswog, Carolina, et al.
Publicado: (2017) -
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
por: Burchett, Katrina M., et al.
Publicado: (2014)